Section I
491 – 500 of 5032
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Phase II LEAP-004 Study of Lenvatinib Plus Pembrolizumab for Melanoma with Confirmed Progression on a Programmed Cell Death Protein-1 or Programmed Death Ligand 1 Inhibitor Given as Monotherapy or in Combination
- Contribution to journal › Article
-
Mark
KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial
- Contribution to journal › Article
-
Mark
ESMO Expert Consensus Statements on the management of breast cancer during pregnancy (PrBC)
- Contribution to journal › Article
-
Mark
Location of Retroperitoneal Lymph Node Metastases in Upper Tract Urothelial Carcinoma : Results from a Prospective Lymph Node Mapping Study
- Contribution to journal › Article
-
Mark
The current use of the EORTC QLQ-NMIBC24 and QLQ-BLM30 questionnaires for the assessment of health-related quality of life in bladder cancer patients : a systematic review
- Contribution to journal › Scientific review
-
Mark
Development and Validation of a Genomic Profile for the Omission of Local Adjuvant Radiation in Breast Cancer
- Contribution to journal › Article
-
Mark
Striving to excel–effects from vacation periods on cancer incidence and outcome
- Contribution to journal › Debate/Note/Editorial
-
Mark
A likelihood ratio approach for utilizing case-control data in the clinical classification of rare sequence variants: Application to BRCA1 and BRCA2
- Contribution to journal › Article
-
Mark
Increased incidence and improved survival in endometrial cancer in Sweden 1960-2014 : a population-based registry survey
- Contribution to journal › Article
-
Mark
The Importance of Perceived Barriers to Women Entering and Advancing in Orthopaedic Surgery in the US and Beyond
- Contribution to journal › Article
